Skip to main content
. 2017 Mar 31;5(1):8–17. doi: 10.1515/jtim-2017-0007

Table 2.

Role of DAA in HCV guidelines

Drug regimen HCV genotype
Sofosbuvir/Ledipasvir +/-Ribavirin Genotypes 1, 4, 5, and 6
Paritaprevir/Ritonavir/Ombitasvir + Dasabuvir +/- Ribavirin: Genotype 1
Sofosbuvir + Simeprevir +/- Ribavirin: Genotypes 1 and 4
Sofosbuvir + Daclatasvir +/- Ribavirin: All genotypes
Paritaprevir/Ritonavir/ombitasvir +/- Ribavirin: Genotype 4
Sofosbuvir + Ribavirin Genotypes 2 and 3

HCV: hepatitis C virus; DDA: direct acting antiviral agent.